Posttreatment antifungal resistance among colonizing Candida isolates in candidemia patients: Results from a systematic multicenter study

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1500-1508

  Jensen, R H ^a   Johansen, H K ^b   Soes L M ^c,d   Lemming, L E ^e   Rosenvinge, F S ^f,g   Nielsen, L ^h   Olesen, B ⁱ   Kristensen, L ^j,k   Dzajic, E ^l   Astvad, K M T ^a   Arendrup, M C ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b University of Copenhagen   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d SLAGELSE HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f LILLEBAELT HOSPITAL   (Denmark)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

ⁱ HILLERØD HOSPITAL   (Denmark)

^j REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

^k Hospitalsenheden Midt ^*  (Denmark)

^l ESBJERG HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; MICAFUNGIN; PYRROLE DERIVATIVE;

AGED; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDEMIA; CONTROLLED STUDY; DRUG EXPOSURE; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS ISOLATION; GENE SEQUENCE; HUMAN; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUTH MUCOSA; MULTICENTER STUDY; MULTILOCUS SEQUENCE TYPING; PREVALENCE; PRIORITY JOURNAL; RESERVOIR; SPECIES DISTRIBUTION; CLASSIFICATION; CLINICAL TRIAL; DENMARK; DRUG EFFECTS; FEMALE; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY;

AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; DENMARK; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING;

EID: 84960421611     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01763-15     Document Type: Article

References (54)

1. Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Røder BL, Schønheyder HC. 2013. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect 19:E343-E353. http://dx.doi.org/10.1111/1469-0691.12212.
2. Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. 2012. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 73:45-48. http://dx.doi.org/10.1016/j.diagmicrobio.2012.02.001.
3. Tortorano AM, Prigitano A, Lazzarini C, Passera M, Deiana ML, Cavinato S, De Luca C, Grancini A, Lo Cascio G, Ossi C, Sala E, Montagna MT. 2013. A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection 41:655-662. http://dx.doi.org/10.1007/s15010-013-0455-6.
4. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35:627-630. http://dx.doi.org/10.1086/342300.
5. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50:3435-3442. http://dx.doi.org/10.1128/JCM.01283-12.
6. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. 2011. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2, 441 patients. Antimicrob Agents Chemother 55:532-538. http://dx.doi.org/10.1128/AAC.01128-10.
7. Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA. 2009. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. An-timicrob Agents Chemother 53:5026-5034. http://dx.doi.org/10.1128/AAC.01031-09.
8. Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D. 2011. Prior caspofungin exposure in patients with hematological malignanciesisarisk factor for subsequentfungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France. Antimicrob Agents Chemother 55:5358-5361. http://dx.doi.org/10.1128/AAC.00690-11.
9. Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK. 2011. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Mi-crobiol 49:3300-3308. http://dx.doi.org/10.1128/JCM.00179-11.
10. Shields RK, Nguyen MH, Press EG, Clancy CJ. 2014. Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimi-crob Agents Chemother 58:7601-7605. http://dx.doi.org/10.1128/AAC.04134-14.
11. Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, Garey KW. 2012. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother 56:3239-3243. http://dx.doi.org/10.1128/AAC.00019-12.
12. Jensen RH, Astvad KMT, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC. 2015. Stepwise emergence of azole, echinocandin and amphotericin B multi-drug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations. J Antimicrob Chemother 70:2551-2555. http://dx.doi.org/10.1093/jac/dkv140.
13. Lockhart SR, Fritch JJ, Meier AS, Schroppel K, Srikantha T, Galask R, Soll DR. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1sequencing. JClin Micro-biol 33:1501-1509.
14. Gammelsrud KW, Lindstad BL, Gaustad P, Ingebretsen A, Høiby EA, Brandtzaeg P, Sandven P. 2012. Multilocus sequence typing of serial Candida albicans isolates from children with cancer, children with cystic fibrosis and healthy controls. Med Mycol 50:619-626. http://dx.doi.org/10.3109/13693786.2012.675088.
15. Brillowska-Dabrowska A, Bergmann O, Jensen IM, Jarløv JO, Arendrup MC. 2010. Typing of Candida isolates from patients with invasive infection and concomitant colonization. Scand J Infect Dis 42:109-113. http://dx.doi.org/10.3109/00365540903348336.
16. Lau AF, Kabir M, Chen SC-A, Playford EG, Marriott DJ, Jones M, Lipman J, McBryde E, Gottlieb T, Cheung W, Seppelt I, Iredell J, Sorrell TC.2015. Candida colonizationasarisk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol. J Clin Microbiol 53:1324-1330. http://dx.doi.org/10.1128/JCM.03239-14.
17. Odds FC, Jacobsen MD. 2008. Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell 7:1075-1084. http://dx.doi.org/10.1128/EC.00062-08.
18. Arendrup MC, Perlin DS. 2014. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27:484-492. http://dx.doi.org/10.1097/QCO.0000000000000111.
19. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, Chen W, Bolchacova E, Voigt K, Crous PW, Miller AN, Wingfield MJ, Aime MC, An K-D, Bai F-Y, Barreto RW, Begerow D, Bergeron M-J, Blackwell M, Boekhout T, Bogale M, Boonyuen N, Burgaz AR, Buyck B, Cai L, Cai Q, Cardinali G, Chaverri P, Coppins BJ, Crespo A, Cubas P, Cummings C, Damm U, de Beer ZW, de Hoog GS, Del-Prado R, Dentinger B, Dieguez-Uribeondo J, Divakar PK, Douglas B, Duenas M, Duong TA, Eberhardt U, Edwards JE, Elshahed MS, Fliegerova K, Furtado M, Garcia MA, Ge Z-W, Griffith GW, Griffiths K, Groenewald JZ, Groenewald M, Grube M, Gryzenhout M, Guo L-D, Hagen F, Hambleton S, Hamelin RC, Hansen K, Harrold P, Heller G, Herrera C, Hirayama K, Hirooka Y, Ho H-M, Hoffmann K, Hofstetter V, Hognabba F, Hollingsworth PM, Hong S-B, Hosaka K, Houbraken J, Hughes K, Huhtinen S, Hyde KD, James T, Johnson EM, Johnson JE, Johnston PR, Jones EBG, Kelly LJ, Kirk PM, Knapp DG, Koljalg U, Kovacs GM, Kurtzman CP, Landvik S, Leavitt SD, Liggenstoffer AS, Liimatainen K, Lombard L, Luangsa-Ard JJ, Lumbsch HT, Maganti H, Maharachchikumbura SSN, Martin MP, May TW, McTaggart AR, Methven AS, Meyer W, Moncalvo J-M, Mongkolsamrit S, Nagy LG, Nilsson RH, Niskanen T, Nyilasi I, Okada G, Okane I, Olariaga I, Otte J, Papp T, Park D, Petkovits T, Pino-Bodas R, Quaedvlieg W, Raja HA, Redecker D, Rintoul TL, Ruibal C, Sarmiento-Ramirez JM, Schmitt I, Schussler A, Shearer C, Sotome K, Stefani FOP, Stenroos S, Stielow B, Stockinger H, Suetrong S, Suh S-O, Sung G-H, Suzuki M, Tanaka K, Tedersoo L, Telleria MT, Tretter E, Untereiner WA, Urbina H, Vagvol-gyi C, Vialle A, Vu TD, Walther G, Wang Q-M, Wang Y, Weir BS, Weiss M, White MM, Xu J, Yahr R, Yang ZL, Yurkov A, Zamora J-C, Zhang N, Zhuang W-Y, Schindel D. 2012. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A 109:6241-6246. http://dx.doi.org/10.1073/pnas.1117018109.
20. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope W, EUCAST-AFST.2012. EUCAST technical note onthe EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect 18:E246-E247. http://dx.doi.org/10.1111/j.1469-0691.2012.03880.x.
21. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW. 2014. EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole. Mycoses 57:377-379. http://dx.doi.org/10.1111/myc.12170.
22. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW. 2013. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp. Drug Resist Updat 16:81-95. http://dx.doi.org/10.1016/j.drup.2014.01.001.
23. Bougnoux M-E, Morand S, Enfert C, d'Enfert C. 2002. Usefulness of multilocus sequence typing for characterization ofclinical isolates of Candida albicans. J Clin Microbiol 40:1290-1297. http://dx.doi.org/10.1128/JCM.40.4.1290-1297.2002.
24. Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 41:5709-5717. http://dx.doi.org/10.1128/JCM.41.12.5709-5717.2003.
25. Jacobsen MD, Gow NAR, Maiden MCJ, Shaw DJ, Odds FC. 2007. Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol 45:317-323. http://dx.doi.org/10.1128/JCM.01549-06.
26. Tavanti A, Davidson AD, Johnson EM, Maiden MCJ, Shaw DJ, Gow NAR, Odds FC. 2005. Multilocus sequence typing for differentiation of strains ofCandida tropicalis.JClin Microbiol 43:5593-5600. http://dx.doi.org/10.1128/JCM.43.11.5593-5600.2005.
27. McManus BA, Coleman DC, Moran G, Pinjon E, Diogo D, Bougnoux M-E, Borecká-Melkusova S, Bujdákova H, Murphy P, D'Enfert C, Sullivan DJ. 2008. Multilocus sequence typing reveals that the population structureofCandida dubliniensisis significantly less divergent than that of Candida albicans. J Clin Microbiol 46:652-664. http://dx.doi.org/10.1128/JCM.01574-07.
28. Muñoz R, Gómez A, Robles V, Rodríguez P, Cebollero E, Tabera L, Carrascosa AV, Gonzalez R. 2009. Multilocus sequence typing of oeno-logical Saccharomyces cerevisiae strains. Food Microbiol 26:841-846. http://dx.doi.org/10.1016/j.fm.2009.05.009.
29. Diab-Elschahawi M, Forstner C, Hagen F, Meis JF, Lassnig AM, Presterl E, Klaassen CHW. 2012. Microsatellite genotyping clarified conspicuous accumulation of Candida parapsilosis at a cardio-thoracic surgery intensive care unit. J Clin Microbiol 50:3422-3426. http://dx.doi.org/10.1128/JCM.01179-12.
30. Enache-Angoulvant A, Bourget M, Brisse S, Stockman-Pannier C, Diancourt L, François N, Rimek D, Fairhead C, Poulain D, Hennequin C. 2010. Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates. JClin Microbiol 48:4028-4034. http://dx.doi.org/10.1128/JCM.02140-09.
31. Chen K-W, Chen Y-C, Lo H-J, Odds FC, Wang T-H, Lin C-Y, Li S-Y. 2006. Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. J Clin Microbiol 44:2172-2178. http://dx.doi.org/10.1128/JCM.00320-06.
32. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP. 2009. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115:4745-4752. http://dx.doi.org/10.1002/cncr.24507.
33. Forrest GN, Weekes E, Johnson JK. 2008. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.JInfect 56:126-129. http://dx.doi.org/10.1016/j.jinf.2007.10.014.
34. Spampinato C, Leonardi D. 2013. Molecular fingerprints to identify Candida species. Biomed Res Int 2013:923742. http://dx.doi.org/10.1155/2013/923742.
35. Perlin DS, Shor E, Zhao Y. 2015. Update on antifungal drug resistance. Curr Clin Microbiol Rep 2:84-95. http://dx.doi.org/10.1007/s40588-015-0015-1.
36. Lott TJ, Frade JP, Lockhart SR. 2010. Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies. Eukaryot Cell 9:619-625. http://dx.doi.org/10.1128/EC.00002-10.
37. Hattori H, Iwata T, Nakagawa Y, Kawamoto F, Tomita Y, Kikuchi A, Kanbe T. 2006. Genotype analysis of Candida albicans isolates obtained from different body locations of patients with superficial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS. J Derma-tol Sci 42:31-46. http://dx.doi.org/10.1016/j.jdermsci.2005.12.003.
38. Gammelsrud KW, Sandven P, Høiby EA, Sandvik L, Brandtzaeg P, Gaustad P. 2011. Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls. Clin Microbiol Infect 17: 1875-1881. http://dx.doi.org/10.1111/j.1469-0691.2011.03528.x.
39. Karaman M, Firinci F, Karaman O, Uzuner N, Hakki Bahar I. 2013. Long-term oropharyngeal colonization by C. albicans in children with cystic fibrosis. Yeast 30:429-436. http://dx.doi.org/10.1002/yea.2977.
40. Soll DR. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13:332-370. http://dx.doi.org/10.1128/CMR.13.2.332-370.2000.
41. Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NAR, Jones BL. 2007. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 56:1066-1075. http://dx.doi.org/10.1099/jmm.0.47239-0.
42. Lott TJ, Frade JP, Lyon GM, Iqbal N, Lockhart SR. 2012. Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities. Med Mycol 50:136-142. http://dx.doi.org/10.3109/13693786.2011.592153.
43. Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ. 2012. The presenceofanFKS mutation rather than MIC is anindependent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother 56:4862-4869. http://dx.doi.org/10.1128/AAC.00027-12.
44. Arendrup MC, Perlin DS, Jensen RH, Howard SJ, Goodwin J, Hope W. 2012. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrob Agents Chemother 56:2435-2442. http://dx.doi.org/10.1128/AAC.06369-11.
45. Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, Hermansen N-O, Larssen KW, Mylvaganam H, Ranheim TE, Sandven P, Nordøy I. 2015. Twenty-two years of candidaemia surveillance-results from a Norwegian national study. Clin Microbiol Infect 21:938-945. http://dx.doi.org/10.1016/j.cmi.2015.06.008.
46. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. 2011. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother 55:561-566. http://dx.doi.org/10.1128/AAC.01079-10.
47. Zhang L, Zhou S, Pan A, Li J, Liu B. 2015. Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013. Int J Infect Dis 33:1-4. http://dx.doi.org/10.1016/j.ijid.2014.12.033.
48. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724-1732. http://dx.doi.org/10.1093/cid/cit136.
49. Farmakiotis D, Tarrand JJ, Kontoyiannis DP. 2014. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis 20:1833-1840. http://dx.doi.org/10.3201/eid2011.140685.
50. Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ. 2013. Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance. Antimicrob Agents Chemother 57:6361-6365. http://dx.doi.org/10.1128/AAC.01451-13.
51. Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA. 2006. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol 44:1740-1743. http://dx.doi.org/10.1128/JCM.44.5.1740-1743.2006.
52. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. 2012. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 36:288-305. http://dx.doi.org/10.1111/j.1574-6976.2011.00278.x.
53. Rodrigues CF, Silva S, Henriques M. 2014. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 33:673-688. http://dx.doi.org/10.1007/s10096-013-2009-3.
54. Jensen RH, Johansen HK, Arendrup MC. 2013. Stepwise development of homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis. Antimicrob Agents Chemother 57:614-617. http://dx.doi.org/10.1128/AAC.01193-12.